Page 7 - Report From News Today

New program from the American Heart Association® and the University of California, San Francisco will speed development of health-tech innovation - New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often failed to make it to patients because all critical stakeholders were not involved at the right phase of the development process to ensure acceptance by patients, payers and providers along the way.

September 2022 Prior to Iran’s 1979 revolution, all political voices were silenced by the Shah, and society suffered extensively from political ignorance.

-- Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and 29% Respectively Relative to Placebo in a Post Hoc Analysis

Investegate announcements from Amarin Corporation plc, New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes

-- Late-Breaking Data Show VASCEPA/VAZKEPA Significantly Reduced STEMI by 40% and NSTEMI by 27% in Pre-Specified, Post Hoc Analyses -- -- Data Presented During Late-Breaking Science Session at European

August 12, 2022 First-ever global consensus guidance published in the Journal of the American College of Cardiology: Cardiovascular InterventionsUse of IVUS recommended in all phases of lower extremity

Investegate announcements from Royal Philips, Vascular experts establish Appropriate Use of Intravascular Ultrasound (IVUS) in peripheral interventions

August 12, 2022 First-ever global consensus guidance published in the Journal of the American College of Cardiology: Cardiovascular InterventionsUse...

Press release content from NewMediaWire. The AP news staff was not involved in its creation.

In recent years, 3D pathology imaging has developed to achieve precision diagnosis. Using AI/ML to reduce the cognitive demands on clinicians and/or...